Figure 1
Overall and disease-free survival curves for 22 enrolled patients. Estimated 3-year survival and disease-free survival rates were 66 and 61%, respectively.
Figure 1 | British Journal of Cancer
Overall and disease-free survival curves for 22 enrolled patients. Estimated 3-year survival and disease-free survival rates were 66 and 61%, respectively.
